Kalmar Investments’s Allergan plc AGN Stock Holding History

Kalmar Investments’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-41,240	Closed	-$12.9M	–	155
2015 Q4	$12.9M	Sell	41,240 -49,285	-54%	-$14.7M	0.32%	102
2015 Q3	$24.6M	Sell	90,525 -53,640	-37%	-$16.5M	0.58%	70
2015 Q2	$43.7M	Sell	144,165 -520	-0.4%	-$155K	0.83%	48
2015 Q1	$43.1M	Sell	144,685 -5,490	-4%	-$1.57M	0.8%	54
2014 Q4	$38.7M	Sell	150,175 -67,780	-31%	-$16.9M	0.72%	61
2014 Q3	$52.6M	Hold	217,955	–	–	1%	34
2014 Q2	$48.6M	Sell	217,955 -100	-0%	-$20.7K	0.84%	47
2014 Q1	$44.9M	Sell	218,055 -64,820	-23%	-$12.8M	0.76%	54
2013 Q4	$47.5M	Buy	282,875 +3,280	+1%	+$513K	0.79%	47
2013 Q3	$40.3M	Sell	279,595 -905	-0.3%	-$121K	0.71%	56
2013 Q2	$35.4M	Buy	+280,500	New	+$31.8M	0.7%	58

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Kalmar Investments's AGN Position: Q1 2016 in Review

Kalmar Investments sold out of Allergan plc (AGN) in Q1 2016, closing a stake of 41,240 shares — an estimated $12.9M sold.

Kalmar Investments first reported a position in AGN in Q2 2013 and held it in 11 quarters. The position peaked at $52.6M in Q3 2014. 1,119 funds tracked by Wall St. Rank hold AGN as of Q1 2016.

Kalmar Investments reported no remaining Allergan plc position as of Q1 2016 after selling out during the quarter.
Kalmar Investments sold 41,240 Allergan plc shares in Q1 2016, an estimated $12.9M.
Kalmar Investments first reported a position in Allergan plc in Q2 2013 and held it in 11 quarters.
Kalmar Investments's Allergan plc position peaked at $52.6M in Q3 2014.
1,119 funds tracked by Wall St. Rank held Allergan plc as of Q1 2016.

Based on Kalmar Investments's 13F filing for Q1 2016, filed 27 May 2016.